HiDO HomeCareSystem for Dementia

This trial explores whether a new tool, the HiDO HomeCareSystem, can help people with dementia take their daily medications more reliably. The system uses face recognition to remind users when to take their meds, aiming to improve overall health outcomes. Participants must have dementia, be on medication for it, and have a caregiver to assist with the study. The trial compares the HiDO system to normal medication routines to determine its effectiveness.

As an unphased trial, this study offers patients the chance to contribute to innovative solutions that could enhance daily living for those with dementia.

You might need to stop taking certain medications if they are contraindicated (not safe to use together) with the study. The research team will review your medications and work with your doctor to decide if any changes are needed before you join the trial.

Previous studies have tested the HiDO HomeCare System for safety and effectiveness in medication management. Research shows that this device uses face recognition to remind patients to take their pills. It assists people with dementia in taking medication correctly, reducing the chances of missed doses or incorrect medication.

The studies primarily focused on the device's effectiveness rather than side effects. The trial is labeled "Not Applicable," indicating insufficient data from early human trials for detailed safety information. However, devices like this are generally considered low-risk and undergo testing to ensure safe use as intended.

The HiDO HomeCare System is unique because it uses face recognition technology to assist individuals with dementia in managing their medication. Unlike traditional methods where patients or caregivers must remember dosing schedules, this system helps monitor and ensure timely medication intake, potentially reducing the chance of missed or incorrect doses. Researchers are excited about this system because it empowers both patients and their caregivers, offering a more personalized and reliable way to manage medication, which may improve overall treatment outcomes and quality of life for those living with dementia.

Research has shown that the HiDO HomeCareSystem, which participants in this trial may use, holds promise for helping people with dementia take their medication as prescribed. Studies indicate that this device overcomes the shortcomings of older medication management tools. It supports correct medication adherence, which is essential for managing dementia effectively. Additionally, the system is linked to better overall care for dementia, offering support to both patients and their caregivers. Early findings suggest the device helps caregivers by reducing stress and improving their ability to manage care. Participants in the trial will be randomized to either use the HiDO HomeCareSystem or continue with Standard Medication Management without the device.¹²³⁴⁶